Bank of America maintained its Buy rating on Novartis shares.
2 reports, 1 independent
Updated Sep 11
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bank of America maintained its Buy rating on Novartis shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Bank of America
American multinational banking and financial services corporation
-
Novartis
Swiss-American multinational pharmaceutical corporation
Related events
- Meta and Tesla faced scrutiny after spending reports, while BofA maintained a Buy rating on Meta stock.
- Bank of America reiterated its Buy rating and maintained the price target for Costco on May 27, 2026.
- Bank of America reiterated a 'buy' rating on stock while companies like Starbucks and Dutch Bros Inc operate and compete in the Texas QSR market.
- Bank of America restated a buy rating on an unnamed company on August 17, 2026.
- Bank of America commented on the failed acquisition bids and strategic review outcomes for CooperVision.